CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer
∙ The RNA Printer® is CureVac’s integrated and automated manufacturing solution for RNA vaccines and…
News
iTeos to Present at the Cowen 42nd Annual Health Care Conference
CAMBRIDGE, Mass. and GOSSELIES, Belgium, March 01, 2022 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq:…
EyePoint Pharmaceuticals to Participate in Fireside Chat at the Cowen 42nd Annual Health Care Conference
WATERTOWN, Mass., March 01, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
Industry Leading Peripheral Nerve Stimulator Upgraded to Improve Patient User Experience with Control of their…
Dyve Biosciences Announces the Appointment of Nicholas A. Saccomano, Ph.D., to its Scientific Advisory Board
– Former Array BioPharma and Pfizer Executive Joins Dyve Biosciences – CAMARILLO, Calif., March 01,…
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
— Preparations continue for U.S. commercial launch in June 2022 in BBS and Alström syndrome,…
Avadel to Present New Clinical Data at World Sleep 2022
Eight abstracts accepted for poster presentation featuring new data from the Phase 3 REST-ON clinical…
Kronos Bio Announces Participation in Cowen 42nd Annual Health Care Conference
SAN MATEO, Calif. and CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) — Kronos Bio, Inc….
Walden Biosciences Announces Participation at 4th Annual Chronic Kidney Disease Drug Development (CKD) Summit
CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) — Walden Biosciences, Inc. (Walden), a private, venture-backed…
First Wave BioPharma Announces Appointment of Sarah Romano as Chief Financial Officer
20-year corporate finance career spans several pharmaceutical and healthcare-focused companies and underscores financial leadership abilities…
Akouos to Present at Cowen 42nd Annual Heath Care Conference
BOSTON, March 01, 2022 (GLOBE NEWSWIRE) — Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic…
Ikena Oncology to Participate in Cowen 42nd Annual Health Care Conference
BOSTON, March 01, 2022 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology…
Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences
NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage…
Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update
– TEMBEXA RFP Response Submitted and Under Review with BARDA – – Pre-Clinical CMX521 Data…
Amicus Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
PHILADELPHIA, March 01, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that members…
Aadi Bioscience to Participate in Panel Discussion on Tumor-Agnostic Development at Cowenās 42nd Annual Health Care Conference
LOS ANGELES, March 01, 2022 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”) (Nasdaq:AADI), a biopharmaceutical…
PolyPid to Present at the Barclays Global Healthcare Conference
PETACH TIKVA, Israel, March 01, 2022 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”),…
AccuStemās StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort
LONDON and PHOENIX, March 01, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTC PINK: ACMSY),…
PLx Pharma Inc. to Present at Oppenheimer & Coās 32nd Annual Healthcare Conference on March 15, 2022
SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the…
Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
Initial Phase 1 Data Readouts from Clinical Trials of XTX101 and XTX202 Anticipated in 2022…